Trametinib 2mg tablets
NHS hospitals in England used £34,053,792 of indicative cost of Trametinib 2mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 3.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Trametinib 2mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Trametinib 2mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £2,882,240 |
| East And North Hertfordshire Nhs Trust | £2,188,160 |
| Royal Surrey County Hosp Nhs Found Trust | £1,392,000 |
| South Tees Hosp Nhs Foundation Trust | £1,392,000 |
| Nottingham University Hospitals Trust | £1,309,280 |
| Maidstone And Tunbridge Wells Nhs Trust | £1,180,800 |
| Sheffield Teaching Hospitals Nhs Trust | £1,137,600 |
| The Christie Nhs Foundation Trust | £1,097,600 |
| The Clatterbridge Cancer Centre Nhs Ft | £1,041,600 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,003,200 |
The primary-care picture
Trametinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Trametinib medicine page.